Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
<h4>Background</h4>Concerns have been raised as to the safety of bisphosphonates; in particular a possible link between bisphosphonate use and upper gastrointestinal (GI) cancer. Two published studies using different study populations but drawn from earlier versions of the same national...
Guardado en:
Autores principales: | Ellen Wright, Peter T Schofield, Paul Seed, Mariam Molokhia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8b7a9d01cbb47c3a3f62d51f6784488 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
por: Richard Derman, et al.
Publicado: (2009) -
Academic impact of a public electronic health database: bibliometric analysis of studies using the general practice research database.
por: Yu-Chun Chen, et al.
Publicado: (2011) -
Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Oliver Bock, et al.
Publicado: (2008) -
Decreased risk of breast cancer associated with oral bisphosphonate therapy
por: Mathew A, et al.
Publicado: (2012) -
Value of age and alarm features for predicting upper gastrointestinal malignancy in patients with dyspepsia: an endoscopic database review of 4664 patients in Thailand
por: Nonthalee Pausawasdi, et al.
Publicado: (2021)